Available in BC2 (2mg 10 vials), BC5 (5mg 10 vials), and BC10 (10mg 10 vials), this product offers flexibility for both small-scale assays and extended experimental protocols
In preclinical models, their combined use in the BPC-157 TB500 Blend 10mg allows researchers to study potential synergistic effects on tissue repair across multiple signalling axes simultaneously, reducing experimental complexity compared to running two separate compounds
High oral bioavailability Caco-2 cell assays showed excellent passive and active membrane transport with no detectable efflux (Neelakantan et al., 2018)
doi:10.1186/s12970-018-0247-6 Sikiric P, Drmic D, Sever M, et al
The rationale for combining these three peptides extends beyond simple additive effects to encompass true biological synergy, where coordinated activation of complementary pathways produces outcomes unattainable by individual components alone